Cathepsin G Inhibitor I

Skip to product information
1 of 1

Selleck Chemicals

SKU:E4453-1MG

Regular price €144,00 EUR
Regular price Sale price €144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

Cathepsin G Inhibitor I is an inhibitor of Cysteine Proteases used in studies of protease biology. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to proteolytic processing and cleavage-dependent signaling in inflammation models.

By inhibiting Cysteine Proteases, Cathepsin G Inhibitor I can be used to examine proteolytic processing and cleavage-dependent signaling. This target class is commonly examined through protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping. In inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Cysteine Proteases
  • Concentration-response inhibition and target-dependence studies
  • Protease-activity, cleavage, and substrate-processing assays
  • Phenotypic profiling in inflammation models

Overall, Cathepsin G Inhibitor I is appropriate when a defined chemical perturbant is needed to connect Cysteine Proteases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Cysteine Proteases
Target Class:
Protease
Research Area:
Inflammation
CAS No.:
429676-93-7
Molecular Weight:
620.63
Formula:
C₃₆H₃₃N₂O₆P
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.